# Using Surveys to Examine the Association of Exposure to ML Mortality Risk Predictions With Medical Oncologists' Prognostic Accuracy and Decision-making

> **NCT06463977** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 52 (actual)

## Conditions studied

- Oncology

## Interventions

- **OTHER:** Survey

## Key facts

- **NCT ID:** NCT06463977
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-13
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06463977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06463977, "Using Surveys to Examine the Association of Exposure to ML Mortality Risk Predictions With Medical Oncologists' Prognostic Accuracy and Decision-making". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06463977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*